TherapeuticsMD Announces FDA Approval of TX-004HR: IMVEXXY (estradiol vaginal inserts), the Lowest Dose Vaginal Estrogen Product Approved for the Treatment of Moderate to Severe Dyspareunia, a Symptom
Go back to TherapeuticsMD Announces FDA Approval of TX-004HR: IMVEXXY (estradiol vaginal inserts), the Lowest Dose Vaginal Estrogen Product Approved for the Treatment of Moderate to Severe Dyspareunia, a Symptom| THERAPEUTICSMD, Inc. (NASDAQ: TXMD) | Delayed: 2.18 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.18 | 52 Week High | $11.26 | |||
| Open | $2.18 | 52 Week Low | $4.39 | |||
| Day High | $2.21 | P/E | N/A | |||
| Day Low | $2.18 | EPS | $-0.22 | |||
| Volume | 7,185 | |||||
